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While much research has examined factors thought to
affect patient compliance with therapeutic regimen, relatively little is known about the relationship between
psychiatric patients' attitudes toward treatment regimen
and their adherence to the treatment regimen.

Compliance

rates for psychiatric patients remain the lowest of the
medical patient population, probably due to psychological
and social characteristics of psychiatric patients.

Be-

cause of a trend in the United States toward self-medication
·-........

for an increasingly ambulatory psychiatric patient population, the ability to predict patient compliance with
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medication regimen has become more important than ever before.

Before potential noncompliers can be identified and

patient compliance predicted through the use of attitudes,

an examination of the nature of these attitudes is needed.
Scientific literature and theory suggest that attitude
is one of several variables which corresponds to behavior.
Specific attitudes are thought to develop as a result of
real or vicarious experience with the attitude referent.

In

addition, research has shown that attitudes toward specific
objects correlate highly with beliefs, behavioral intentions,
and behavior.

Therefore, it is hypothesized that psychiatric

patients with prior medicine-taking experience will have developed different patterns of attitudes toward

pharmacologi~

cal treatment than will medicine-naive patients.

The hypo-

thesis implies that knowing these attitudes will permit prediction of compliance of experienced and naive patients with
therapeutic regimen.
As the first step of investigating using attitudes to
predict compliance, a 20-item Likert-type rating scale, the
Psychiatric Medicine Attitude Scale (PMAS), was developed.
An alternate forms reliability coefficient of .93 was obtained.

Mean score for Form A for the psychiatric medicine-

experienced subjects was 2.85, for the medicine-naive subjects, 3.40.

Form B scores were 3.17 for the experienced

subjects and 3.51 for the naive subjects.

These scores show

that on both Forms A and B, individuals without prior experience with psychiatric medicine tended tb express more neg-
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ative attitudes toward the referent object than did the subjects who had previous medicine experience.
The next steps, outside the range of this project, will
be to develop norms and to ascertain if compliance behaviors
will be a function of PMAS scores.

DEVELOPING AN ATTITUDE TEST TO PREDICT TREATMENT OUTCOME

IN DEPRESSED AND ANXIOUS OUTPATIENTS:
AN EXPLORATORY STUDY

by

KATHRYN AINSLIE PARIS

A thesis submitted in partial fulfillment of the
requirements for the degree of

MASTER OF SCIENCE
in.

PSYCHOLOGY

Portland State University

1983

TO THE OFFICE OF GRADUATE STUDIES AND RESEARCH:
The members of the Committee approve the thesis of
Kathryn Ainslie Paris presented December, 1982.

Barbara J'8tewart, Chairperson

Richard

Wollert

APPROVED:

f Psychology

rch

ACKNOWLEDGMENTS
I am grateful for this opportunity to acknowledge the
substantial contributions of my committee members, Drs.
Barbara Stewart, Vincent Glaudin, and Richard Wollert, to
this research.

Each is a true educator who encouraged both

my personal and academic growth during the thesis work.
As chairperson, Dr. Stewart's influence was significant.
Very clearly, she provided the support which enabled the
completion of the project.

She also offered important crit-

ical evaluation and encouraged scientific curiosity at every
stage of the work.

She approached each task enthusiastically,

making even the more obscure aspects of scientific examination manageable and interesting.

I treasure her memos which

included "some interesting notions about research" from
Robert Pirsig's Zen and the Art of Motorcycle Maintenance.
In addition to her academic support, Barbara's friendship
was a lifeline during a turbulent period of my life.

Besides

modeling a successful and human, personal and professional
style, she was available at school and at home whenever I
needed her consultation.

I am indebted to her and I miss her

now.
To Dr. Glaudin goes credit for the very idea of the project.

In addition, he directed and facilitated the research

in such essential ways as providing bibliographic search

iv

support and supplying a clinical population.

I benefited

from both his remarkable command of scientific theory and his
clinical acumen.

Dr. Glaudin was also unusually accessible

during the process and would encourage the smallest spurts of
progress between regrettably long months of inertia.

I would

be very fortunate to work with an individual of his expertise
and kindness again.
Although Dr. Wollert was invited to participate in the
latter stages of the project, his comments and evaluation
were always clear and useful.
as well.

I appreciate his friendship

His participation rounded out the most caring and

proficient thesis committee a graduate student will ever
have.

TABLE OF CONTENTS
PAGE
ACKNOWLEDGMENTS .

.

..

. . . .

iii
vii

LIST OF LISTS . .
LIST OF TABLES

. . . . . . . . .

. viii

CHAPTER
I.

INTRODUCTION

1

Clinical History of Compliance

2

Magnitude of Compliance and Noncompliance .

3

Determinants of Compliance

4

Patient factors . . . . .
Features of the illness .
Patient-therapist relationship
Features of the medication regimen
Treatment milieu
. . . . . . .
II.

STATEMENT OF THE CLINICAL PROBLEM

10

Theoretical Foundations ; .

13

Definitions of attitude . . . . . . . . . . . .
Attitude meas_urement using commitment-free
responses . . . . . . . . . . . .
Personal and situational variables
Attitudes and compliance
III.

5
5
7
8
9

13

14
15
16

METHOD

18

Part I-Scale Development

18

S ub j e ct s

. . . . . . .
. . . .
Instrument . . . . . . . . .
. . . . . . .
Analysis and development of scale for Part II .

Part II-Scale Refinement

18
18
19
20

vi
PAGE

CHAPTER
Subjects .
Instrument
Procedure
Analysis .

IV.

RESULTS

.
.
.
. . . . .
. . . . . . . .
. . . .
. .

20
21
21
21

. .
. ..
.
. . . . . . .
. . . . . .

. . . . . . .

.. . ...

23

Descriptive Data
Factor Analyses

V.

23

. . . . . . . .

28

Alternate Form Construction (25-item PMAS)

29

Scale Refinement

41

DISCUSSION . . .

43

Content Description
Factor Patterns

. . . . . . . . . . . . .
.... ... .

43

47
48

Reliability
Directions for Future Research·

REFERENCES
APPENDICES .

... . .. ..
. . . . . . .
.

49

51
55

A.

Initial Structured Interview

56

B.

177-Item Attitude Questionnaire

60

c.

80-Item PMAS . . . .

73

D.

Psychiatric Medicine Attitude Scale

80

LIST OF LISTS
PAGE

LIST
!

IT

Directional Differences of Item Responses

24

. . . . . . . . .

30

Sample Items

. . .

IIT

List of 25-Items on Form A of the PMAS

N

List of 25-Items on Form B of the PMAS

. . .
. . .

31
34

LIST OF TABLES
PAGE

TABLE

!
II

Item Statistics for Form A of the PMAS . .

37

Item Statistics for Form B of the PMAS . . .

39

CHAPTER I
INTRODUCTION
One of the most valuable contributions clinical research can make to the practice of mental health care is to
strengthen the clinician's ability to predict treatment response.

It is generally recognized that psycholog1cal char-

acteristics of patients play a significant role in determining treatment outcome.

Particularly worthy of clinical

study are those psychological variables which influence compliance with or adherence to treatment regimen.
Research results provide evidence which indicates that
a patient's beliefs and feelings influence his or her treatment adherence, and that by studying the patient's attitudes
toward following treatment regimen, rather than the patient's
personality, compliance can be predicted (Rosenstock, 1974;
Valins & Nisbett, 1971).
As an exploratory study, the major tasks of this project
are threefold:

to review the

~linical

history of compliance,

to summarize the theoretical issues regarding the relationship between the patient's attitudes and treatment adherence,
and to develop a practical and reliable test to measure a
patient's attitude toward taking psychiatric medicine.
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Clinical History of Compliance
Clinicians find the ability to identify potentially
noncompliant patients vital where pharmacological adherence
often means the difference between outpatient and inpatient
status.

Early identification of potential noncompliers

increases treatment efficiency by reducing the number and
extent of drug trials, conserving medical resources, and
encouraging· greater involvement of the patient in the
treatment regimen.

Health educators note that greater

patient involvement in treatment results in more rapid
recovery (Barsky, 1976; Mathews, 1976).
Three major reviews chronicle the increasing interest
in the compliance problem first detailed by Bergman and
Werner (1963) and later by Porter (1969).

In their book

written for the "1974 Workshop/Symposium on Compliance with
Therapeutic Regimens," Sac.kett and Haynes (1976) prepared
an annotated bibliography of 246 articles published
by 1973.

Pothier (1975) compiled a bibliography of

74 references on compliance from.the National Library
of Medicine.

And, most pertinent to this study, using

the above studies and an earlier review of his own,
Blackwell (1976) extracted and examined 55 articles which
concerned compliance with medication regimens of psychiatric patients.
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Magnitude of Compliance and Noncompliance
Compliance is defined generally as, "the extent to
which the patient's behavior (in terms of taking medica-

tions, following diets, or executing other life-style
changes) coincides with the clinical prescription" (Sackett
& Haynes, 1976, p. 1).

Compliance with medication regimens

is usually measured in terms of rate of omission, some
range of medicine-taking defined "compliant" by the investigators, for example, 80% to 120% of prescribed daily
dosage.

Blackwell (1976) found the rate of complete omis-

sion (taking no medication at all) among psychiatric outpatients to vary from 25% to 50%.

Compliance as measured

by pill count for neurotic outpatients on randomized medication trials was reported to range from 23% to 54%; the
former percentage when compliance was defined as taking
all the prescribed medicine, the latter when compliance
was defined as intake within 25% of the prescribed amount
(Lipman, Rickels, Uhlenhuth, Park, & Fisher, 1965; Rickels

& Briscoe, 1970).

A study of psychiatric outpatients

taking phenothiazines yielded a compliance rate, measured
by urine assay, of 65% (Irwin, Weitzel!, & Morgan, 1971).
These studies reveal that clinicians should expect their
psychiatric outpatients to comply with medication regimen
alone, from between 23% to 75% of the time.
Distribution patterns might be as important as
adherence rates in determining compliance.

A study by
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Gordis, Markowitz, and Lilienfeld (1969) shows a U-shaped
distribution of compliance behavior.

They found that one-

third of the patients were totally noncompliant, one-third

took almost all medication prescribed, and the remaining
third were scattered in between.

The practical implica-

tions of a U-shaped distribution pattern of compliance are
different than those implied by consideration of a statistically normal distribution curve.

To thoroughly evaluate

the magnitude of the compliance problem, continued research
on distribution pattern as well as average rates is needed.
Determinants of Compliance
A review of factors thought to influence compliance
supports Porter (1969) in his conclusion that "every patient
is a potential defaulter" (p. 222).

While this comment

may appear cynical, contrary to popular wisdom most helping
professionals generally err in predicting their patients'
treatment adherence.

In the 1976 review by Sackett and

Haynes, none of the five articles reporting research on
the ability of the therapist to predict patient adherence
found any association between therapist
actual patient compliance.

predi~tions

and

Other researchers have corrob-

orated and updated these results with the finding that
physicians' accuracy in predicting patient compliance did
not improve as familiarity with the patient increased
(Roth & Caron, 1978; Roth, Caron, & Hsi, 1971).

Neverthe-

less, certain determinants appear regularly in the
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scientific literature on compliance.

These variables in-

clude certain patient factors, features of the illness,
the patient-therapist relationship, features of the medica-

tion regimen, and the treatment setting.
Patient factors.

When correlating demographic fac-

tors with keeping scheduled appointment for mixed diagnoses
patient samples, most reports in the Sackett and Haynes
(1976) review found no link between sex, age, education,

marital status, race, nor religion and the compliant behavior.

When examining the data for medication adherence

alone, Blackwell (1976) found no patient fac.tors which
consistently decreased adherence to medieal regimens.

He

did, however, discover four factors which tended to increase treatment compliance:

(a) considering the disease

a serious one, (b) family stability, (c) compliance with
other aspects of treatment, and (d) patient satisfaction
with treatment.

The family stability factor is related

to the variable of supervision by spouse or partner, a
factor which dramatically increases medication adherence
(Parkes, Brown, & Monck, 1962; Porter, 1969; Renton,
Affleck, Carstairs, & Forrest, 1963; Willcox,
Hare, 196"5).

Gil~n,

&

That psychiatric patients, often: social1y with-

drawn, are least compliant of the medical patient population is not surprising in light of these findings.
Features of the illness.

Within the general medical

patient population, few significant correlations are
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observed between treatment compliance and features of the
disease such as severity, duration, previous bouts, recency
of last attack, previous hospitalizations, degree of dis-

ability, and symptoms.

By

isolating psychiatric diagnoses

in terms of disease severity, duration, and consequences
of ceasing medicine, however, identification of noncompliers
becomes more possible.

In general, psychiatric patients,

especia1ly schizophrenics with paranoid features and
patients with personality disorders, are significantly
less compliant than patients with an organic diagnosis
(Sackett & Haynes, 1976; Wilson & Enoch, 1967).

For

psychiatric patients, other investigators found that
adherence worsens as the severity of diagnosis increases,
suggesting that the ability to cooperate is impaired among
the chronic, more disabled patients (Blackwell, 1976).
Nonadherence was highest in schizophrenics most ill at
time of discharge, for example.

The same researchers found

that those patients with less severe diagnoses attended
outpatient clinics and adhered to medication more faithfully (Renton et al., 1963).

Among neurotics, the most

anxious outpatients with poorest prognoses and histories
of prior treatment elsewhere had lowest adherence (Lipman
et al., 1965).
Besides disease severity, the consequences of stopping
medicine are related to noncompliance among psychiatric
patients.

For example, when patients with diagnoses of
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manic-depressive illness or schizophrenia interrupt their
medication regimen, their symptoms do not reappear immediately upon cessation of medicine.

Therefore, the con-

sequences of these patients' noncompliance are delayed.
Without experiencing an immediate negative consequence,
conditions are established which support defaulting rather
than medicine-taking.

As Blackwell (1973) notes, patients

adhere to medication therapies more carefully when relapse
is severe or immediate, and tend to be less compliant as
the duration of remission increases.
Patient-therapist relationship.

Because research

has shown patient compliance to be higher in private practice than in clinics, the relationship between patient and
therapist is important in the study of compliance (Blackwell,
1972).

Although this variable is complex and obviously

intercorrelated with the continuity of care topic, certain
relevant findings have emerged from the study of the
general medical patient population.
Sackett and Haynes (1976) report that the patient's
general satisfaction with the therapist and the clinic,
and his or her conclusion that the therapist had met the
patient's expectations, both correlate positively with
treatment compliance.

The specific elements to which

patients attend when rating satisfaction or dissatisfaction
with their therapist have received little evaluation in
scientific literature, however.

To date, satisfaction in
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the patient-therapist relationship has been approached from
study of contributing environmental characteristics and
therapist attitudes primarily.

Studies have shown that

more positive therapist attitudes toward the patient and
toward the role of medicine in treatment, as shown by more
positive affective responses, more optimistic treatment
prognoses, and a belief in medication as essential, tend
to increase patient adherence (Irwin et al., 1971; Shapiro,
1974).

An earlier report revealed that therapists with the

most compliant patients were more reassuring about side
effects and expected gains (Reynolds, Joyce, Swift, Tooley,
& Weatherall, 1965).

Adherence with regimen also declined

when a second physician was substituted for the regular
caretaker (Becker, Drachman, & Kirscht, 1972).

Again, the

above investigations have used general medical populations;
unfortunately little research has been published on the
therapist-patient relationship as it relates to compliance
within a psychiatric population.
Features of the medication regimen.

Research on

general medical patients has shown consistently that compliance is adversely affected when drugs are given in
frequent, divided doses, and when multiple medications are
prescribed.

In addition, side effects correlate with dis-

continuing medication, as might be expected (Porter, 1969;
Renton et al., 1963).

Different compliance rates have

been found for alternative drugs and alternate methods of
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administration, but as Sacket and Haynes (1976) note,
these findings are inconsistent.
The degree of behavior change required also correlates

with adherence.

Sackett and Haynes (1976) found a relation-

ship where least behavior change required by the treatment
regimen relates to highest regimen compliance, and high
required behavior change correlates with lower compliance.
It appears that compliance worsens as new medicine taking
behavior is required, decreases further if changing old
behavior is necessary, and is lowest when breaking personal
habits such as smoking or drinking becomes necessary for
regimen compliance.

This pattern may explain the findings

noted earlier of decreased adherence with increasingly
complex regimens.
Treatment milieu.

In general medicine, adherence

can be increased by managing environmental variables such
as patient waiting time in the clinic or office, increasing
convenience of clinic and pharmacy, and by simplifying
intake and scheduling procedures (Irwin et al., 1971;
Raynes & Warren, 1971).

Few studies are available on the

effect of the treatment setting on compliance for the
psychiatric patient.

We can assume that factors which

exacerbate continuity of patient care and minimize the
degree of supervision and support can only have a negative
effect upon the patient whose illness reduces his or her
awareness of treatment efforts in the first place.

CHAPTER II
STATEMENT OF THE CLINICAL PROBLEM
The problem of compliance with therapeutic regimen
continues to challenge health care professionals.

With

increasing use of oral medications, more responsibility for
self-medication is shifting to the patient at a time when
few factors are known to predict clearly compliance behavior.
Research has shown that less disabled psychiatric patients
with more intact social support systems, enduring relationships with caring health professionals, and simple medication schedules, adhere to treatment plans more consistently
than the more disturbed patients who have less social support, less familiar physicians, and more complicated treatment regimens.
Researchers see hope that patient education can
increase compliance but results to date are contradictory.
In certain cases, medicine compliance increases with more
knowledge and instruction, but other reports show the
most knowledgeable general medical patients to be the most
flagrant noncompliers (Carpenter & Davis, 1976).
The Health Beliefs Model (HBM) suggests that a
patient's motivation to take preventative health action
affects compliance with treatment.

According to this
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model, factors defining a readiness to act include the
patient's perceived susceptibility to the disease, his or
her perception of disease severity, the patient's judgment

of treatment feasibility and efficacy, and attention to
internal and external cues to action (Rosenstock, 1966).
Experimental evaluation of the HBM has yielded inconsistent
results.

Perceived severity of the disease enhanced

adherence in cystic fibrosis patients (Meyers, Dolan, &
Mueller, 1975).

In hypertensive patients, however, only

the perception of the social consequences of being ill
predicted compliance (Taylor, cited in Sackett, 1978).
Blackwell (1976) suggests that educational strategies like
the HBM err in their emphasis on fear as a motivator; he
describes the paradoxical effects which result when some
patients are urged by threat of debilitation to comply with
treatment.

Like the alcoholic driven to drink out of fear

of cirrhosis, the noncompliant patient avoids anxiety by
forgetting his or her medication, a reminder of sickness.
Further contradiction of the assumption that people are
motivated by the negative valence of disease is the
evidence that illness seems to fulfill an important
function in some lives.

Examples of patients refusing help

abound in clinical literature.

See the Simonton's work

with cancer patients, Ellerbroek's treatment of acne
vulgaris patients, the apparent preference for a grandiose
psychosis among some noncompliant schizophrenics, and
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Minuchin's studies of psychosomatic families (VanPutten,
Crumpton, & Yale, 1976; Ellerbroek, 1978; Minuchin, Rosman,

& Baker, 1978; Simonton & Simonton, 1975).

In those cases where improving compliance is truly
beneficial, where as Sackett (1978) states, treatment is
known to do more good than harm, where low compliance is a
documented problem, and where low compliance interferes
with treatment goals, a test inquiring about patient
attitudes toward treatment has much practical value.

A

recent study by Sackett (1977) supports identifying
patients' attitudes.

Sackett learned that hypertensive

patients who admitted noncompliance improved significantly
when offered help with medicine-taking strategy.

Those who

verified their compliance but who were, in fact, not
complying, did not improve.

It is suggested that surveying

attitudes can predict patient compliance with medication
regimen.
It is proposed that a Psychiatric Medicine Attitude
Scale (PMAS), constructed to measure a patient's attitude
toward using psychiatric medicines, will be useful in
screening for potential noncompliers among a psychiatric
patient population.

If an attitude-compliance relationship

can be determined, the PMAS will provide an objective index
to compare a given patient's attitudes with those of other
patients, and will aid in identifying those most likely to
benefit from special efforts directed toward compliance
with treatment regimen.
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Theoretical Foundations
Through the mid-1960's, social scientists continued to
assert the inconsistent relationship between attitudes and
behavior.

Evidence of the inconsistency began with

LaPiere's now classic (although flawed) 1934 study of
discrepancy between general attitudes toward minority groups
and behavior toward a specific Chinese couple.

Since the

late 1960's, however, researchers armed with new theories
and methodology have begun to study attitudes with renewed
interest and even optimism (Kelman, 1974).

Most current

investigators accept the existence of an attitude-behavior
relationship and concern themselves with the circumstances
within which attitudes correlate with behavior.

This

section will address probability and latent process
definitions of attitude, attitude measurement using
commitment-free responses, the role of personal and
situational variables in the attitude-behavior equation,
and attitudes and behavioral compliance in view of the
theoretical findings.

(General methodological variables

have also been found to influence conceptualization of the
correlation between attitude and behavior, but their
discussion is beyond the scope of this paper.

For an

excellent review of these factors, the reader is directed
to Stewart's 1977 summary.)
Definitions of attitude.

DeFleur and Westie (1963)

postulate that two general conceptions underlie historical
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definitions of attitude.

These categories are probability

conceptions and latent process conceptions.

Differences

between them involve the inferences to be made about

attitudinal responses.

Adherents of the probability

definition state that attitudinal responses are consistent
in most situations; behavior toward a specific attitudinal
stimulus has a probability of recurring in a particular
direction.

The latent process definitions take the

probability concept a step further and give the behavior a
hypothetical anchor.

Latent process theorists see attitude

as the mediating variable by which consistencies of
behavior can be explained.

To paraphrase Stewart (1977),

probability theorists do not expect attitude-behavior
consistency across situations because, while attitudes and
behaviors might be correlated, they are caused by different
variables.

Attitude-behavior inconsistency is an issue for

the latent process theorists, on the other hand, because,
since attitude is for them an intervening variable, it is
one of the causes of behavior.
Attitude measurement using commitment-free responses.
The purpose of defining attitude is to enable its
measurement.

This investigation used a model for attitude

measurement based on latent process theory.

Goodmanson and

Glaudin in 1971 proposed a suitable paradigm which used as a
measurement criterion the amount of commitment a response
carries.

They proposed that response consequences lie on a

commitment-free to committed behavior continuum.

In the
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Goodmonson and Glaudin model, attitude is a latent or
intervening variable which can be inferred from
commitment-free responses to an attitude test.

Because

attitude is viewed as one of the causes of behavior, in
this model attitude-behavior inconsistency can be
attributed to the impact of other variables on behavior.
Using the latent process definition of attitude, the
problem of measuring attitudes toward psychiatric medicine
becomes one of developing a reliable instrument which would
permit commitment-free responses concerning the referent
subject.

Much attitude research has examined racial,

political, and religious issues, subjects which are
constrained by powerful social behavioral guidelines.

In

comparison, the topic of psychiatric medicine is relatively
free of inherent social expectancies and therefore seems an
appropriate psychological object for attitude research.
Personal and situational variables.

Before the

mid-1960's, personal and situational variables were deemed
error variance in most attitude research (Fishbein, 1967).
More recently, researchers have begun to include
investigation of personal and situational variables in their
examinations of the attitude-behavior correlation (Liska,
1975).

Empirical evidence supports this theoretical

shift.

In her review, Stewart (1977) found that personal

variables such as verbal skills, intellectual and social
abilities, activity level, self-perception as a doer, ego
involvement, and deliberate inconsistency, influenced the
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attitude-behavior relationship.

While intuitively and

empirically, individual factors appear to affect behavior,
a computer-aided literature· search yielded no reports of

studies concerning the effect of these types of personal
variables on attitudes of psychiatric patients.
Attitudes have been further categ9rized as attitudes
toward the specific object, toward the action itself, and
toward the situation (Kelman, 1974).

Normative beliefs

also have been suggested as a situational variable which
may influence the attitude-behavior relationship (Fishbein,
1 967)

.
On the basis of previous literature, this author

expected attitudes toward psychiatric medicine, toward
taking psychiatric medicine, and toward being in a situation
in which psychiatric medication thera.py is indicated, to be
some of the attitudinal variables which interact with
certain personal variables to influence a psychiatric
patient's medicine-taking.

Further, beliefs of his or her

peer or cultural groups likely influence the individual's
attitude toward the referent object.

It would be

efficacious to include these variables in any examination
of the factors thought to affect the attitude-behavior
correlation.
Attitudes and compliance.

As noted earlier, latent

process attitude theory suggests that attitude is one of the
intervening and personal variables which have been found to
influence any action situation.

It also was noted that a
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literature review revealed that the topic of attitudes of
psychiatric patients toward specific aspects of psychiatric
medicine and psychiatric medicine-taking has been ignored
by

scientific journals.

Other research suggests that

attitude toward psychiatric medicine can be determined from
responses to a commitment-free questionnaire.

This study

proposed to develop an attitude scale for use in future
research examining the effect of attitudes on psychiatric
patients' medicine-taking behavior.

Attitude theory and

data from empirical investigations indicate that such a
scale would be enhanced by inclusion of statements
concerning attitudes toward psychiatric medicine, toward
taking such medication, toward being required to take
psychiatric medication, and influences from the normative
group.
If a reliable questionnaire were devised, this would
be a tool to facilitate research on several unanswered
questions.

An attitude questionnaire would be useful in

determining the parameters of a psychiatric patient's
attitudes toward his or her therapy, would allow
comparisons of the patient to other groups, and would
initiate the study of the influence of attitude on
compliance with prescribed therapy regimen.

Given good

validity data, potential uses of an attitude scale would
include the differentiation of patients likely to be
non-compliers from the remaining psychiatric population.

CHAPTER III
METHOD
Part I-Scale Development
Subjects.

The development of the questionnaire item

pool began by interviewing 15 patients undergoing medical
and psychological treatment for depression and anxiety in
various treatment facilities.

Inpatient facilities

included a rural state hospital 20 miles from a mediumsized city in the Pacific northwest and a Veteran's Administration Hospital in that

~ity.

The other setting was a

pr.ivate outpatient clinic operated by a psychiatrist and
a clinical psychologist in the same·city.

The average age

of the eight female patients was 39.6 years, of the seven
males, 34.9 years.

Of these patients, five women and

six men had prior psychiatric medicine experience.
Instrument.

A structured interview was constructed

which covered specific and general attitude content dimensions.

The interview included questions regarding

general attitude toward taking psychiatric medicine,
vulnerability toward illness, efficacy of psychiatric
medicine, pleasant and unpleasant aspects of psychiatric
medicine, schedule followed when prescribed medicine,
factors which enhanced or inhibited schedule adherence,
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changes experienced if any, and attributions about the
changes when taking psychiatric medicine or failing to take
psychiatric medicine (see Appendix A).
Analysis and development of scale for Part II.

Upon

analysis, patient responses to the structured interview
appeared to fall into six content dimensions:

fear of

physical addiction, fear of emotional dependency, the use
of psychiatric medicine as covering up problems, risk versus
safety of the medicine, trust in the h€lping professional,
and obligation or duty to take prescribed medicine.

To

generate additional material, concepts from attitude and
health education literature were used-to supplement the
above data.

Questions in four areas, the influence of

significant others, belief in medicine efficacy, the need
for information about the medicine, and the belief that
medicine improved cognitive efficiency, were added.
Finally, items from the Health Belief Model were included
as the 11th content dimension (Rosenstock, 1974).

These

latter items concerned general health motivation, perceived
susceptibility toward the illness, perceived severity of
the illness, and probability that compliant behavior would
reduce threat of illness.

All items were constructed using

as much original wording from the structured interview data
as possible.

Sentences were written in brief and

self-referent form.

(See Appendix B for a copy of this

177-item questionnaire.)
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The 177 items were evaluated by eight health care
professionals for expression of positive, negative, or
ambiguous attitude toward psychiatric medicine, after

Thurstone (1931 ).

Judges' agreement about expression of

valence was tabulated for each item.

Four items

consistently judged positive and four judged negative were
extracted from each content dimension, building a list of
80 items.

(See Appendix C for 80-item PMAS.)

The Health

Belief Model items yielded inconsistent ratings from the
judges and were deleted from the item pool at this stage.
Part II-Scale Refinement
Subjects.

Subjects for the scale refinement phase

were 126 introductory psychology college students enrolled
at a metropolitan state university in the same city
mentioned earlier, and 30 outpatients

rec~iving

medical and

psychological treatment for depression and anxiety in the
previously noted clinic.

Questionnaires with more than 10

percent of the questions unanswered were discarded.

Six

student questionnaires and one outpatient form were
unusable, resulting in usable questionnaires from 149
subjects.
Of these, 65 subjects met the criterion for inclusion
in the "experienced" sample; the criterion for inclusion was
experience regarding psychiatric medicine, either reported
personal experience and/or experience through that of a
close friend or relative.

The experienced subjects (30
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outpatients and 35 students) included 33 females and 32
males, mean ages of 32.33 years.

The naive subjects, n

=

84, included 43 females and 41 males with an average age of

23.88 years.

The experienced subjects as a group were

significantly older (p < .001) than the medicine-naive
subjects.
Instrument.

The 80-item PMAS was used.

Items were

rated on a six point scale from "strongly agree" (1) to
"strongly disagree" (6).

An informed consent form was

attached to each questionnaire following university
procedure.

Although signatures were required on the consent

forms, anonymity was secured by detaching the consent forms
from the questionnaires before data analysis.
Procedure.

Students were administered the

questionnaire during regular class time.

Subjects from the

outpatient clinic completed the questionnaire at the time of
their initial visit.

Questionnaires typically required 10

minutes for completion.

Data collection proceeded for six

months from December 1978 through May 1979.
Analysis.

The resulting data were analyzed in a four

step process of scale refinement.
The descriptive data were analyzed first.

Frequency

distributions of item responses were examined and responses
of the experienced and naive subjects were contrasted on a
per item basis using two-tailed t tests.
Then, correlation matrices for the 80 PMAS items were
computed for each group separately (experienced = E, and
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naive= N) and together (T).

The three resulting 80 x 80

matrices were factor-analyzed using the principle components
method.

After initial factoring, the factors having

eigenvalues of 1 .000 and greater were rotated to an
orthogonal Kaiser normalized Varimax solution for each
group.

Prominent factor patterns were noted.

Third, factor patterns from the E, N, and T data were
compared.

Items with loadings of

~40

and greater were

selected from prominent and content-similar factors for E
and T groups.

Alternate forms, designated Forms A and B,

comprised of 25 items each were developed.
Finally, Pearson product-moment correlations were
computed to examine the item-total correlations for each of
the preliminary 25-item versions of the PMAS.
scales were pared to 20-item final versions.

The 25-item
Alternate

form reliability was computed by correlating total scores
of the 20-item version of Form A with that of Form B.

CHAPTER IV
RESULTS
The following results were obtained from responses of
the 149 subjects to the 80-item PMAS.

Results from each

step of scale development, analysis of descriptive data,
factor analyses, alternate form construction, and scale
refinement, are described.
Descriptive Data
Item means ranged from 1.70 to 5.20 on the six point
scale from strongly agree (1) to strongly disagree (6).

The

experienced subjects expressed consistently greater response variability than did the naive subjects.
The experienced subjects responded in a significantly
different direction, E. ( . 01, than the naive subjects on
54% of the items.

List I shows examples of items on which

the E mean response differs from that of the N mean
response.
To summarize their differences,. the experienced
subjects tended to agree with items which expressed more
confidence in medical help, more willingness to follow
medication directions, less fear of possible physical and
cognitive side-effects from psychiatric medication, less
fear of addiction, and less concern about social censure

24

UST I
DIRECTIONAL DIFFERENCES OF ITEM RESPONSES
XE

xN

1.49

1.92

E subjects agreed more than N subjects:

If psychiatric medicine were prescribed for me,

I would follow the directions carefully.

(8)

2.86

2.46

I feel it would be necessary for me to comply
with a prescription for psychiatric medication. (10)

2.91

3.42

I would put up with some uncomfortable medication side-effects in order to get over a
serious depression. (14)

3.31

3.75

Psychiatric medicine might give me the energy
to think clearly if I were depressed. (18)

2.37

2.99

I think some problems can be faced up to better
with the support of psychiatric medications. (36)

3.02

3.38

I would take psychiatric medication prescribed
for me because I think it is pretty effective. ( 40)

4.43

4.79

When I have emotional problems, I want psychiatric medicine prescribed for me. (48)

2.34

3.01

I take my medication regularly regardless of
what my family thinks of it. (53)

2.00

2.62

I think it's always best to seek medical help
for severe depression. (61)

2.56

3.21

Psychiatric medicines which are prescribed by
a doctor have been carefully screened by
scientific studies. (65)

3.52

4.18

I have no qualms about trying psychiatric medication my doctor recomends. (68)

2.43

3.10

I think a patient should take prescribed psychiatric medicine even if family and friends
don't understand. (69)

3.97

4.55

I'll try whatever psychiatric medicine my
doctor recommends. (72)

2.31

2.81

Other people's opinions would never stop me
from taking the medication I need. (80)
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LIST I (con'd)
xE

xN

3.62

3.15

E subjects disagreed more than N subjects:
Psychiatric medicines usually cover up problems

that should be faced.

(5)

4.25

3.64

Even carefully prescribed psychiatric medicines
are much too risky.
(9)

4.55

3.70

I

2.94

2.56

Psychiatric medications are habit-forming.

3.80

3.13

I believe all psychiatric medicines present a

don't believe in psychiatric medicines.

very real danger of addiction.

(12)
(13)

(16)

5.60

5.23

Whether you take prescribed psychiatric medicine
exactly as directed just isn't very important.
( 17)

3.42

2.98

I believe people should face their problems

without psychiatric medicine.

(19)

5.15

4.57

Unless friends kept encouraging me to take
prescribed psychiatric medicine, I would
stop.
(22)

4.03

3.56

I would not take prescribed psychiatric medicines because they take the edge off my
thinking.
( 24)

4.77

4.25

The only value psychiatric medicine has comes
from the power of suggestion.
(26)

3.74

2.89

I'm afraid that if I took a prescribed psychiatric medicine, I would become dependent
on it.
(28)

2.54

1.94

A patient should reject psychiatric medication
unless every detail is explained carefully.
( 30)

3.08

2.60

I think it's wrong to take medicine all the
time because if your thinking is dulled,
you don't have a good sense of when you're
well.
(31) (Item withdrawn from consideration.)

3.49

2.96

Having to take psychiatric medicines is no way
to live.
( 33)
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LIST

xE

xN

5.06

4.37

I ( con ' d)

I would not take prescribed psychiatric medi-

cation even if every detail were explained
to me.

( 37)

4.88

4.46

If my family seemed uninterested in my treatment, I would throw prescribed psychiatric
medicine down the sink.
(42)

5.00

4.33

I would not take psychiatric medication pre-

scribed for me if my family and friends
seemed very interested.
(44) (Item
withdrawn from consideration.)

3.71

3.31

I believe psychiatric medication usually makes
thinking fuzzy.
(45)

2.06

1.60

I would be hesitant to take psychiatric medication prescribed for me without knowing all
about it.
( 4 7)

4.88

4.18

I don't care how safe a psychiatric medication
is reported to be, I still wouldn't take
it.
( 50)

4.58

3.74

I believe psychiatric medicines basically
poison the body.
(54)

4.68

4.17

Psychiatric medicines are too weak to help
treat big problems.
(58)

2.77

2.27

I see psychiatric medicine as a last resort to
coping with emotional problems.
(63)

3.98

3.24

You can't expect a patient to take psychiatric
medication if no one cares.
(64)

3.77

2.95

Even though psychiatric medicine might help
with emotions, it usually makes it harder
to think clearly.
(67)

3.97

3.36

I think psychiatric medications almost always
block you from having feelings you should
experience.
(70)
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LIST

I

(con ' d)

xE

xN

3.66

3.13

Once you begin taking psychiatric medicine, it
is hard to give it up.
(73)

4.85

4.26

All the medical information in the world
couldn't convince me to take psychiatric
medication.
(75)

Note.

1 = strongly agree; 6 = strongly disagree. Numbers
in parentheses at the end of each item indicate the
item number on the 80-item PMAS.
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regarding taking prescribed psychiatric medicine, than did
the medicine-naive subjects.
Factor Analyses
An examination of the factor patterns for the
experienced and naive subjects and for the total group was
made for the purpose of selecting items for the final
scale.

In this process, somewhat more emphasis was placed

on the results of the factor pattern of the experienced
subjects.

This was done because of the observation that

many patients beginning psychiatric outpatient treatment
had had prior somatic therapy elsewhere (Glaudin, 1979).
It seemed likely that the attitude patterns of the
medicine-experienced subjects would correlate best with
those of the population on which the questionnaire
eventually would be used.

In developing the content

dimensions, those prominent factors from the pattern of the
experienced subjects which included at least two items with
high and/or similar loadings were selected.

The latter

criterion was used for the purpose of developing two
alternate forms.

Corroboration of the resulting content

dimensions was sought within the factor patterns of the
total group.

The factor patterns of the total sample

appeared to parallel considerably the ten factors from the
experienced subject sample.
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Analysis of the factor patterns yielded ten prominent
factors.

These were labeled, (a) information, (b) dangers,

(c) coping, (d) need, (e) remembering, (f) addiction, (g)

details, (h) friends, (i) authority, and, (j) emotions.
List I I

shows sample items from each factor.

Alternate Form Construction (25-item PMAS)
Through the process of factor analysis described in
the methods section, items suitable for inclusion in
alternate forms of a preliminary (25-item) PMAS were
derived.

A number of quantitative and qualitative criteria

for item selection were used.

Desirable items were those

which (a) met Thurstone (1931) analysis criteria (low
ambiguity), (b) represented all categories of endorsement,
(c) represented the 10 content dimensions, and (d) had
varying degrees of content specificity.

In addition, items

on which the experienced subjects differed significantly
from the medicine-naive subjects were balanced with items
on which the two groups responded similarly.

The last

criterion was style, with briefer and self-referent items
being preferred.

Lists III

~nd

IV

show the 25 items of

Forms A and B of the PMAS.
As can be seen from Tables r-and II, three items (53,
56, and 63) of the final 50 selected did not have loadings
on .40 or higher in the factor pattern of the total group.
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LIST I I

SAMPLE ITEMS
1.

Information

Once I had the medical facts carefully explained to
me, I would take necessary psychiatric medication.
2.

Dangers
I think psychiatric medicines usually have bad side
effects.

3.

Coping
Psychiatric medicine can help provide the energy to
face overwhelming problems.

4.

Need
I would take psychiatric medication I needed whether
I liked the doctor or not.

5.

Remembering
It is easy for me to neglect taking my medication
when I get busy.

6.

Addiction
Psychiatric medications are habit-forming.

7.

Details
A patient should reject psychiatric medication unless
every detail is explained carefully. (Omitted in
final PMAS.)

8.

Friends
Unless friends kept encouraging me to take prescribed
psychiatric medicine, I would stop. (Omitted in final
PMAS.)

9.

Authority
I have no qualms about trying psychiatric medication
my doctor recommends.

10.

Emotions
I would be relieved to find out that a close friend
was taking medication for depression.
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LIST III
LIST OF 25-ITEMS ON FORM A l}F THE PMAS

Factor 1.

Information

Once I had the medical facts carefully explained to me,
1 would take necessary psychiatric medication.
(35)
I would not take prescribed psychiatric medication even
~f every detail were explained to me.
(37)
I think a patient should take prescribed psychiatric
medicine even if family and friends don't understand.
(69)
I don't believe in psychiatric medicines.

(12)

I would put up with some uncomfortable medication sideeffects in order to get over a serious depression.
(14)
Even carefully prescribed psychiatric medicines are much
too risky .
(9)
I would take psychiatric medication prescribed for me
because I believe it is pretty effective.
(40)
The trouble with psychiatric medicines is that they just
don't work.
(38)
Factor 2.

Dangers

Once you begin taking psychiatric medicine, it is hard
to give it up.
(73)
I think psychiatric medicines usually have bad side
effects.
( 34)
·Even though psychiatric medicine might help with emotions,
it usually makes it harder to think clearly.
(67)
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LIST III (con'd)
Factor 3.

Coping

I believe prescribed psychiatric medicines usually would

make a patient's thinking clearer because of less
anxiety.

( 74)

·Psychiatric medicine can help provide the energy to face
overwhelming problems.
(46)
I believe psychiatric medications can make it po~sible
to learn new behavior in frightening situations.
(77)
Factor 4.

Need

I would take prescribed psychiatric medication for the
sake of my loved ones.
(7)
It would be impossible for me to take psychiatric medicine from a doctor I didn't trust.
(62) Omitted
Factor 5.

Remembering

It is easy for me to neglect taking my medication when
I get busy.
(55)
No matter how busy I get, I always remember to take my
medication on time.
(43) Omitted
Factor 6.

Addiction

·carefully prescribed psychiatric medicines have no
danger of addiction.
(41) Omitted
Whether you take psychiatric medicine exactly as prescribed just isn't very important.
(17)
Factor 7.

Details

A patient should reject psychiatric medication unless
every detail is explained carefully.
(30) Omitted

33
LIST III (con'd)
Factor 8.

Friends

Unless friends kept encouraging me to take prescribed

psychiatric medicine, I would stop.
Factor 9.

(22)

Omitted

Authority

I

would take psychiatric medication prescribed for me
and not worry about scientific details. (56)

I

have no qualms about trying psychiatric medication
my doctor recommends. (68)

Factor 10.
I

Emotions

would be relieved to find out that a close friend was
taking medication for depression. (15)

Note.

Numbers in parentheses at the end of each item
indicate the item number on the 80-item PMAS.
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LIST IV
LIST OF 25-ITEMS ON FORM B OF THE PMAS
Factor 1.

Information

Having the scientific information would in~luence me to
take psychiatric medication prescribed for me.
(39)
I don't care how safe a psychiatric medication is reported
to be, I still wouldn't take it.
(50)
·If the doctor explains what effects the medicine might
have on me, I would take it as prescribed.
(59)
All the medical information in the world couldn't convince me to take psychiatric medication.
(75)
I think some problems can be faced up to better with the
support of psychiatric medications.
(36)
Psychiatric medicines usually cover up problems that
should be faced.
(5)
I think taking psychiatric medicine is a realistic method
to lessen discomfort.
(20)
I would rather have psychological counseling forever than
take psychiatric medicines.
(23)
Factor 2.

Dangers

I'm afraid that if I took a prescribed psychiatric medicine, I would become dependent on it.
(28)
I believe psychiatric medication usually makes thinking
fuzzy.
(45)
-I think psychiatric medications almost always block you
from having feelings you should experience.
(70)

Factor 3.

Coping

Psychiatric medicine might give me the energy to think
clearly if I were depressed.
(1)
I think prescribed psychiatric medication can help
patients concentrate better.
(52)
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LIST IV (con'd)
Frequently, patients can learn new ways of coping because
psychiatric medicines break up old anxiety patterns.
(66)
Factor 4.

Need

·I would take psychiatric medication I needed whether I
liked the doctor or not. (60)
I would never take psychiatric medicine from a doctor
I didn't have full confidence in.
(27) Omitted
Factor 5.

Remembering

It would be easy for me to forget to take my medicine.
(76) Omitted
I take my medication regularly regardless of what my
family thinks of it.
(53)
Factor 6.

Addiction

·One of the best things about most psychiatric medication is that there is no risk of addiction.
(21)
Psychiatric medications are habit-forming.
Factor 7.

(13)

Details

A patient should reject psychiatric medication unless
every detail is explained carefully.
(30) Omitted
Factor 8.

Friends

Unless friends kept encouraging me to take prescribed
psychiatric medicine, I would stop.
(22) Omitted
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LIST IV (con'd)
Factor 9.

Authority

I'll try whatever psychiatric medicine my doctor recom-

mends.

(72)

I would be hesitant to take psychiatric medication prescribed for me without knowing all about it.
(47)
Factor 10.

Emotions

I see psychiatric medicine as a last resort to coping
with emotional problems.
(63) Omitted

Note.

Numbers in parentheses at the end of each item
indicate the item number on the 80-item PMAS.

.75

.76

.75

.65

.75

.78

.70

.52

.59

.55

.54

.53

69

12

14

9

40

38

73

34

67

74

46
.50

.53

.54

.58

.50

.70

• 77

.74

.63

.74

• 77

.78

37

.78

Item
Total
Corr 25

.80

Item
Total
Corr 20
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Item
No.

2.95 (1.45)

3.12 (1.44)

3. 77 (1.41)

3.57 (1.40)

3.66 (1.63)

4 .88 ( 1.33)

3.02 (1.32)

4.25 (1.51)

2. 91 ( 1.84)

4.55 (1.65)

2.43 (1.67)

5 .06 (1.35)

2.31 (1.39)

Mean (SD)E

3.12 (1.32)

3. 30 ( 1.13)

2.95 (1.01)

3. 35 (1.16)

3 .13 (1. 24)

4.46 (1.23)

3.38 (1.31)

3.64 (1.27)

3.42 (1.58)

3. 70 (1.50)

3.10 (1.29)

4.37 (1.44)

2.51 (1.29)

Mean (SD)N

6 ( .44)

2 ( . 46)

2 ( . 70)

2 ( • 76)

6 ( . 50)

1 ( .48) 16 ( .41)

16 ( • 73)

1 ( .53)

1 (-.63)

1 ( . 70)

18 ( .44)

1 (-.48)

1 ( • 68)

1 ( • 77)

1 (-.80)

Factor Number
(Loading)E

ITEM STATISTICS FOR FORM A OF THE PMAS

TABLE I

2 ( • 65)

2 ( .50) 20 ( .40)

1 ( .58)

1 ( .66) 15 (-.42)

1 ( • 66)

1 ( • 54) 15 ( - • 41)

15 ( .52)

1 ( .46) 15 (-.61)

15 ( .61)

15 (-.57)

15 ( .65)

15 (-.71)

15 ( • 77)

Factor Number
(Loading)T

-:i

w

Omitted '

.32

Omitted

Omitted

.4 7

.62

.57

41

17

30

22

56

68

15

Note.

<

3.71 (1.79)

3.52 (1. 78)

5.02 (1.21)

5.15 (1.31)

2. 54 ( 1. 61)

5. 60 ( . 76)

4.29 (1.54)

3. 22 ( 1.68)

3. 38 (1.85)

2.12 (1.47)

<

.001.

4. 06 (1.44)

4.18 (1.45)

5.21 (1.01)

4.57 (1.37)

1. 94 (1.13)

5. 22 (1. 28)

4. 26 (1.24)

3.46 (1. 55)

3.19 (1.56)

2.21 (1.44)

3.65 (1.45)

3.20 (1.28)

.002, all others significant·at .E..

.57

.63

.51

.25

.29

.32

.24*

.30

.35

.23*

3. 77 (1.91)

3. 00 (1.47)

18 ( .57)

7 ( . 68)

7 ( • 75)

8 ( • 91)

6 ( . 86)

14 ( .82)

5 (-.59)

4 ( • 80)

4 (-.88)

3 (-.44)

3 ( • 80)

1 (-.47)

2 ( • 58)

Item Total Corr

12 ( .47)

10 ( • 45)

7 ( .74)

6 ( • 78)

18 ( .67)

5 ( • 77)

4 (-. 77)

4 ( • 86)

3 ( • 68)

7 ( • 69)

25

2 ( .63) 15 ( .43)

w
co

Data on Mean, Standard Deviation, Factor Number and Loading were derived from 25-item scale analyses.

Item Total Corr 20 refers to item-total correlations for the 20 item Form A;
refers to item-total correlations for the 25-item Form A.

*significant at .E..

Omitted

.30

43

55

Omitted

.35

.35

7

62

.so

.57

77

TABLE I (con'd)

3.31 (1.54)
3. 23 ( 1.36)

.65
.74
.60
.63

.70
.49

.55

.68

.75

.63

.63

.70

.69

.60

.61

.67

.53

.60

59

75

36

5

20

23

28

45

70

18

52

.62

.60

.69

.67

.76

.75
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3.97 (1.55)

3.71 (1.42)

3. 74 (1.65)

3.95 (1.82)

2.78 (1.37)

3. 62 ( 1. 74)

2.37 (1.33)

4.85 (1.63)

2 .68 (1. 60)

4. 88 (1.58)

2.45 (1.37)

.55

.60
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Mean (SD)E

Item
Total
Corr 25

Item
No.

Item
Total
Corr 20

3.43 (1.02)

3. 75 ( 1.33)

3. 36 ( 1. 24)

3.31 (1.29)

2.89 (1.31)

3 .60 (1. 72)

3.08 (1. 28)

3.15 (1.38)

2.99 (1.28)

4.26 (1.60)

3.00 (1.33)

4 .18 ( 1. 54)

2.57 (1.18)

Mean (SD)N

2 ( • 58)

2 ( .41)

2 ( • 68)

2 ( • 76)

1 ( .48) 16 ( .42)

6 ( . 56) 16 ( • 44)

16 ( • 73)

1 ( • 56)

1 (-.54)

1 ( • 66)

1 (-.65)

1 ( .65) 11 ( .40)

1 (-.72)

1 ( .71)

1 (-.68)

Factor Number
(Loading)E

ITEM STATISTICS FOR FORM B OF THE PMAS

TABLE II

13 ( .64)

2 ( • 49)

1 ( • 64)

1 ( .75)

1 ( .73)

16 ( .54)

15 ( • 52)

1 ( • 54)

2 ( .44) 15 .( .47)

15 (-.64)

15 ( • 62)

15 (-.69)

15 ( • 68)

Factor Number
(Loading)T

'°

w

Omitted

.60

.42

.57

Omitted

Omitted

.61

.47

Omitted

76

53

21

13

30

22

72

47

63

Note.

.32

Omitted

27

2.77 (1.73)

2 .06 (1. 33)

3.97 (1.90)

5.15 (1.31)

2. 54 (1.61)

2.94 (1.40)

4. 71 (1. 36)

2. 34 (1. 64)

3.68 (1.66)

1.92 (1.43)

3.62 (1.76)

2. 72 (1.44)

2.27 (1.46)

1.60 ( .87)

4. 55 (1.44)

4.57 (1.37)

1. 94 (1. 34)

2. 56 (1. 22)

4. 99 (1.08)

3.01 (1.53)

3.82 (1.41)

1.99 (1.21)

3. 98 (1.54)

2.83 (1.17)

4 ( • 50)

18 (-.55)

7 (-.66)

7 ( . 73)

8 ( .91)

6 ( .86)

4 ( .40) 16 ( .60)

5 (-.81)

1 (-.64)

4 (-.73)

3 (-.55) 15 ( .41)

3 ( .66)

2 ( .57)

6 ( • 59)

10 ( .46)

7 ( .74)

6 ( • 78)

1 ( • 59)

5 ( • 59)

3 ( • 76)

3 ( • 77)

3 (-.50)

2 ( . 68)

Data on Mean, Standard Deviation, Factor Number and:·Loading were derived from 25-item scale analyses.

Item Total Corr 20 refers to item-total correlations for the 20 item Form B; Item Total Corr 25
refers to item-total correlations for the 25-item Form B.

.31

.51

.61

.32

.33

.55

.42

.59

.31

.45

.46

60

.62

.63

66

TABLE II, (con'd)

-l=='

0
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Scale Refinement
To reduce the time required for completion of the
PMAS, the number of attitude questions was limited to 20 on
each form.

Pearson product-moment correlations were

performed on each 25-item form.

Item-total correlations

for the 25-item Form A ranged from .78 to .23 with a median
correlation of .54.

Item-total correlations for the

25-item Form B ranged from .76 to .31 with a median of .60.
The five items having the lowest correlations with
total score were deleted from each scale.

As Table II

shows, items 22, 30, 41, 43, and 62 were omitted from the
25-item Form A.

Items 22, 27, 30, 63, and 76 were dropped

from the 25-item Form B.
Pearson pruduct-moment item-total correlations were
rerun on the 20-item scales.

The item-total correlations

on the final version of Form A ranged from .80 to .30 with
a median correlation of .5s.

The 20-item Form B item-total

correlations ranged from .75 to .42, and had a median
correlation of .62.

(See Appendix D for copies of the

20-item PMAS scales.)
These calculations reflect the moderate to strong
degree of internal consistency of each scale.

Reliability

between the 20-item Forms A and B was .93, significant at
the p < .001 level.

The mean score for the experienced

subjects on the 20 items which comprise Form A was 2.85,
and on the 20 which make up Form B, was 3.17.

The mean
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score for the naive subjects on the 20-item Form A was 3.40
and on the Form B, was 3.51.

Again, greater response

variability of the experienced subjects was noted.

In

summary, reliability checks showed adequate internal
reliability between the alternate forms.

These data

demonstrate that the task of developing an easily
administered and reliable commitment-free instrument to
measure attitudes toward psychiatric medicine among
medicine-experienced and medicine-naive patients was
accomplished.

CHAPTER V
DISCUSSION
These results describe the development of a paper and
pencil scale evaluating attitudes toward psychiatric
medicine.

The investigation revealed that several content

dimensions emerged from the data on attitudes.

It also

appeared that individuals with prior personal or vicarious
experience with the referent object tertded to respond to
the questionnaire in a qualitatively different manner and
with more variability of endorsement per item than did
those with no prior

psychiatric-med~cine

experience.

Scientific literature indicates the possibility of
predicting behavior once attitudes, as measured on a
commitment-free instrument, are known.

This section will

discuss content of the attitude dimensions, the factor
patterns which resulted, reliability of the results
obtained, as well as directions for future research with,
and use of, the PMAS.
Content Description
As noted earlier, the medicine-experienced subjects
responded differently than did the medicine-naive subjects
to the instrument.

In general, although their response

variability was greater, the experienced subjects responded
more positively toward the referent topic.

The more
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positive response pattern was evident in both general and
specific item content.

Experienced individuals disagreed

strongly (mean responses of 4.55 and 4.58, respectively)
with global items such as, "I don't believe in psychiatric
medicines," and, "I believe psychiatric medicines basically
poison the body."

At a more specific content level, they

agreed (mean responses 1.49 and 2.00, respectively) with
items of this type:

"If psychiatric medicine were

prescribed for me, I would follow the directions
carefully," and, "I think it's always best to seek medical
help for severe depression."
A closer examination of the descriptive statistics
shows- the more positive attitude of the experienced group
to have several components.

The experienced group endorsed

items which indicated (a) willihgness to comply with
medication instructions, (b) belief in the efficacy of
psychiatric medicine (specifically that it helps one face
problems and permits clear thinking), (c) trust in the
scientific information about the safety of psychiatric
medicine, (d) disregard for possible somatic or cognitive
side-effects, (e) minimal fear of addiction to.psychiatric
medicine, and, (f) disregard of social censure for taking
psychiatric medicines.

These findings suggest that

previous experience with the attitude object minimizes some
general prejudices about psychiatric medicine, such as that
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it covers up problems, clouds one's thinking and is
addictive.
In discussing the more positive attitudes of the

experienced subjects, it is important to note again the
mean age differences between the two samples.

The

experienced subjects tended to be in their early 30's and
the naive subjects tended to be in their early 20's.

The

influence of age in this measurement of attitude toward
psychiatric medicine remains unclear.

Since the group of

medicine-experienced subjects is relatively small (n = 65)
the argument could be made that a restricted sample was
obtained.

H.owever, it is likely that, as a function of

living independently and facing life's traditional
stressors such as jobs and significant relationships for a
longer period of time, more people in the older sample will
have sought psychiatric help for emotional problems than in
the younger group.

It is possible that experience with the

referent or therapy in general as well as a tendency to
think more flexibly as one matures, apparent in their more
varied responses, fostered the more positive attitude shown
by this sample of medicine-experienced individuals.

While

it is also possible to speculate that the attitudes of the
older, experienced subjects had evolved from a more
negative position such as that endorsed by the younger,
naive subjects, it is impossible to verify this hypothesis
without a longitudinal study or at least a retrospective
pretest.

Even then, the validity of the latter could be
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questioned.

The former was unfortunately outside the realm

of this research and will remain for future investigations.
Information about dimensions of attitudes toward

psychiatric medicine and differences in attitude as a
function of experience or age could be useful to
professionals who treat psychiatric patients.

If validity

work on the PMAS establishes a relationship between
attitude toward psychiatric medicine and compliance with
therapeutic regimen, scale results could help close the gap
between therapists' assumptions and patients' behavior
noted in the introduction of this report.
These results imply that the patient-doctor
relationship is important in subtle ways as the patient
builds experience with

~sychiatric

medicine.

The large

body of psychological research on placebo effects supports
this implication.

Attitudes could be influenced by how the

patient is treated by the prescribing professional, the
professional's confidence in the medicine, the competence
and caring shown by the staff; it could be that simple
conditioning accounts for the attitudes expressed and that
any internal stimulus or external event contiguous to the
medicine-taking could influence the regard with which the
individual holds the experience.
for research.

This is a fertile area

In any case, it is obvious that the

patient-doctor relationship carries much potential for
influencing beliefs and thoughts.

It seems plausible that
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these influences affect behavioral intentions toward
psychiatric medicine and treatment adherence.
Factor Patterns
Because of the modest sample size, generalizations
from the factor analyses are presented as suggestions for
dimensions of attitude patterns.

The results of this study

show clearly, however, that the attitudes toward psychiatric
medicine are multidimensional.

The relationship between

positive and negative attitudes is not simply a linear one
stretching from positive feelings at one pole and negative
attitudes on the opposite.

Rather the options surveyed

seem rich and intercorrelated.

In addition, responses of

individuals with different medicine-taking histories
suggest future differences in commitment behavior, such as
compliance with medication regimens and perhaps even
therapy outcome.
The factor patterns basically support the original 10
experimental content dimensions.

For our samples, attitudes

toward psychiatric medicine include these dimensions:

(a)

feelings about trusting scientific information about
psychiatric medicine, (b) fears of somatic and cognitive
dangers from taking psychiatric medicine, (c) belief that
medicine helps one handle problems of living, (d) need for
the medication, (e) feelings about remembering to take
prescribed medication as directed, (f) beliefs about
psychiatric medicine's potential for addiction, (g) need to
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have details about the medicine explained, (h) feelings
about the influence of friends and family upon
medicine-taking behavior, (i) belief in the attending

authority to prescribe the best medicine for the patient,
and (j) belief in the efficacy of medicine for specific
complaints such as depression or anxiety.
The PMAS attempted to capture the complexity of these
attitudes by representing these content dimensions in the
final version of the scale.

This project is an initial

study, and it is hoped that future research will
investigate the accuracy and predictive validity of the
content dimensions of the scale.

Of special interest is a

model of the attitude structure of compliant and
noncompliant patients.

The factors obtained in this

investigation begin to outline the range and content of
attitudes patients have toward psychiatric medicine.

These

analyses suggest that the development of a cognitive model
for attitudes toward psychiatric medicine is possible.

Even

before extensive validity testing of the instrument and
development of norms, it appears that the PMAS can have
utility in a clinical setting.
Reliability
As noted in the results section, the internal and
alternate forms consistency was good.

The scale was found

to be a reliable instrument for the sample tested.
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Directions for Future Research
As noted earlier, the validation of the PMAS remains
to be done.

In addition, the results obtained in this

investigation suggest several areas for continued research
with the scale.
Because the normative sample is small, the development
of more extensive norms is advised.

It is also suggested

that future research focus on verifying the reliability
through more extensive standardization and investigating
more thoroughly the affective components of attitude.

It

is expected that obtaining PMAS scores on a larger number
of medicine-experienced patients will produce a somewhat
lower response variability within this group as a whole.
Standardization on a larger sample would also permit more
extensive examination of the factor patterns found in this
exploratory work.

If a relationship is found between

positive attitude as measured by the PMAS and compliance
with regimen, it will be interesting to evaluate the
differences in the attitude factors endorsed by both
experienced and naive individuals.

More conclusive

evaluation of the factor patterns would be possible given
larger norms.
Another area for future research is in the development
of specific scales or subscales for different presenting
complaints.

For example, factor 10 was interesting because

the only apparent relationship among its items was that
each sentence contained the word "depression" or the word
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"anxiety."

This suggests that these specific words cue

certain beliefs or feelings, indicating possible
differences in the patterns of attitudes about general

psychiatric treatment and treatment for specific complaints
such as anxiety or depression.

If validity work results in

the expected relationships between attitude and treatment
compliance, it might prove useful to develop separate
scales for different presenting disorders.

Since in

attitude measurement, it is believed that the more specific
the referent topic, the more predictive the scale, PMAS's
for complaints of depression, pain, or anxiety, could have
definite clinical utility (Kelman, 1974).
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APPENDICES

APPENDIX A
INITIAL STRUCTURED INTERVIEW
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INITIAL COMPLIANCE INTERVIEW WITH PSYCHIATRIC OUTPATIENTS
We are involved in a research study investigating how people
feel about taking psychiatric medicine. This study is
designed to find out the relationship between attitude and
following the medication directions.
Your information is a critical part of this study. From the
information you give us, we hope to build the basic
questionnaire of the study. The questionnaire developed
from your information will be used to survey a large number
of people who, for differing reasons, are taking
psychiatric medicine. The interview has 16 questions about
how you feel about taking medicine, what things help you
take it on time, what prevents you from taking it, and what
changes you feel because of the medicine.
During this interview, we hope that you will represent your
own thinking and feelings, as well as what you think others
believe.
Do you have any questions?
interview.

1.

If not, let's start the

In general, how would you describe your attitude
toward taking psychiatric medicine?

1a.

What do you think about other people taking
psychiatric medicine?

1b. · What do you think of taking medication for
nervousness (anxiety), depression, or
sleeplessness?

2.

Some people feel vulnerable to illness.

2a.

58
In general, how likely is it that you b ecome 1"11?.

2b.

If you do get sick, how severe do you expect the
illness to be?

2c.

How worried would you be if a close friend your
age became depressed?

3.

To what extent do you feel that taking psychiatric
medicine is helpful in treating depression?

4.

Taking medicine has some aspects that are more pleasant
than others.
4a.

What about taking psychiatric medicine is
pleasant?

4b.

What about taking psychiatric medicine is
unpleasant?

5.

When you are given a prescription, what kind of
schedule do you tend to follow for taking the medicine?

6.

What sorts of things prevent you from taking medication
as prescribed?
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7.

What kinds of things help you with taking the medicine
on schedule?

8.

What kinds of changes do you experience when you take
psychiatric medicine that has been prescribed for you?

Sa.

If there has been a change in the way you felt
since beginning treatment, to what do you
attribute these changes?

9.

What changes occur when you fail to take psychiatric
medicine that has been prescribed for you?

10.

Is there anythirgelse that I've forgotten to ask you
about taking psychiatric medicine?

APPENDIX B
177-ITEM ATTITUDE QUESTIONNAIRE
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MEASURING ATTITUDES TOWARD TAKING PSYCHIATRIC MEDICATION
Questions for reviewers:
1.

Is the item readable?

If not, how could it be improved?

2.

Does the item express a positive or negative attitude?
Please put a plus sign, minus sign, or a question mark
in front of each item to tell us if you think the
attitude conveyed is positive, negative, or unclear,
respectively.

3.

What content areas have we left out?

1.

PHYSICAL ADDICTION
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Carefully prescribed psychiatric medicines have no danger
of addiction.
One of the best things about most psychiatric medications is
that there is no risk of addiction.
I would be able to take psychiatric medications as
prescribed with no risk of addiction.
I believe all psychiatric medicines present a very real
danger of addiction.
I think most people tend to become physically dependent on
the psychiatric medications prescribed for them.
I'm afraid that if I took a prescribed psychiatric medicine,
I would become dependent on it.
I would take prescribed psychiatric medicine for a few days
only.
Most prescribed psychiatric medicines are safe to take over
a period of months.
I could take prescribed psychiatric medicines without
becoming dependent on them.
Psychiatric medications are habit-forming.
Once you begin taking psychiatric medicine, it is hard to
give it up.
It is too easy to become dependent upon psychiatric
medicine.
I think it's unlikely that someone my age would become
dependent upon psychiatric medicine.
I think most people are afraid of the possibility of drug
dependency.
I would not worry about becoming addicted to a psychiatric
medicine prescribed for me.
I feel certain that taking psychiatric medicine for more
than just a few days leads to physical dependency upon it.
I'd be very afraid of getting hooked on psychiatric
medicines.

2.

EMOTIONAL DEPENDENCY VS. STOIC INDEPENDENCE
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I don't like relying upon medication to solve emotional
problems.
I would prefer to put up with my problems rather than take

psychiatric medicine.
I'd tend to rely on psychiatric medication less than other
people do to solve my problems.
Psychiatric medicine is only an emotional crutch.
It is too easy for me to depend upon psychiatric medication
to handle my emotions.
I would be relieved to find out that a close friend was
taking medication for depression.
I believe people should face their problems without
psychiatric medicine.
I believe a person should be strong enough to live without
psychiatric medications.
Anyone who has chronic depression anticipates any help they
can get to relieve it.
I handle all my' problems without help from others.
I don't believe in psychiatric medicines.
I would rather suffer than use psychiatric medicine.
I'm against psychiatric medicine because it is just a
crutch.
Psychiatric medication can help with all kinds of problems.
Taking psychiatric medication is not the moral way to live.
I would rather take psychiatric medicine than be extremely
depressed.
When I have emotional problems, I want psychiatric medicine
prescribed for me.
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I think taking psychiatric medicine means you are weak.
In my opinion, taking psychiatric medicine is a lot better
than having constant anxiety.
I would rather commit suicide than take prescribed
psychiatric medicine.
Having to take psychiatric medicines is no way to live.
I would be disgusted to find out that a friend of mine was
taking psychiatric medication.
Letting the depression run its natural course is the right
way to get well.
I think it's always best to seek medical help for severe
depression.
My life is too short to spend it suffering from emotional
problems.
I know that if I needed psychiatric medication to live, I
would consent to it.
A person would be a fool not to take psychiatric medicine
when he really needs it.
Taking psychiatric medicine would prove that I can't handle
my problems on my own.

3.

COVER UP PROBLEMS VS. LEARN-FACE-FACILITATE

Psychiatric medicines usually cover up problems that should
be faced.
I think some problems can be faced up to better with the
support of psychiatric medications.
I believe psychiatric medications can make it possible to
learn new behavior in frightening situations.
Frequently, patients can learn new ways of coping because
psychiatric medicines break up old anxiety patterns.
I would rather rely on psychological help and not take
psychiatric medications prescribed for me.
Psychiatric medication can help provide the energy to face
overwhelming problems.
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Frequently, psychiatric medication counteracts
discouragement so patients can tackle tough problems.
I think psychiatric medications make people too comfortable
to face their problems.
Psychiatric medicines seem to reduce people's motivation
for new learning.
I think psychiatric medications almost always block you
from having feelings you should experience.
I believe psychiatric medicines are prescribed too easily
for routine problems.
I would rather have psychological counseling forever than
take psychiatric medicines.
I see psychiatric medicine as a last resort to coping with
emotional problems.
Psychiatric medicine is there to make life easier for you.
Taking psychiatric medicine conceals the problem.
It's important to realize the limitations of psychiatric
medicine.

4.

INFLUENCE OF SIGNIFICANT OTHERS

I would take prescribed psychiatric medication for the sake
of my loved ones.
If my family seemed uninterested in my treatment, I would
throw prescribed psychiatric medicine down the sink.
Unless friends kept encouraging me to take prescribed
psychiatric medicine, I would stop.
You can't expect a patient to take psychiatric medication
if no one cares.
I think a patient should take prescribed psychiatric
medicine even if family and friends don't understand.
I take my medication regularly regardless of what my family
thinks of it.
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If my family encouraged me, I would take psychiatric
medication prescribed for me.
If my spouse took medication regularly, I would be more
inclined to take mine.

My family always insisted that I take the medication
recommended by my doctor.
I would not take psychiatric medication prescribed for me
if my family and friends seemed very interested.
I prefer to follow my family's guidance about taking
psychiatric medication.
I would avoid the advice of friends in considering
psychiatric medicines for my problems.
Other people's opinions would never stop me from taking the
medication I need.

5.

EFFICACY

Prescribed psychiatric medications are usually effective.
Psychiatric medicines do little good in relieving important
symptoms.
I would take prescribed psychiatric medicines if they were
more effective than they are.
I would take psychiatric medication prescribed for me
because I believe it is pretty effective.
Psychiatric medicines are too weak to help treat big
problems.
The best thing about psychiatric medicines is that they
work.
The trouble with psychiatric medicines is that they just
don't work.
It's really all in your head; if you think a psychiatric
medicine is going to work, it will work.
The only value psychiatric medicine has comes from the
power of suggestion.

Being more relaxed is something you can count on from
taking psychiatric medicines.
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Psychiatric medicines can help us return to a more normal
way of living.
I think taking psychiatric medicine is a realistic method
to lessen discomfort.
I see taking psychiatric medicine as necessary to a better
functioning body.
I'm convinced that it isn't natural to reduce emotional
suffering by using psychiatric medication.
I think it's a sad waste to deny a person the medicine
necessary to good emotional health.
I think people should take psychiatric medicine if they're
anxious and nervous.
I see psychiatric medicine as a powerful tool in treating
depression and nervousness.
If I can't sleep, or if I get a headache, a mild
tranquilizer is a good idea.

6.

RISK VS SAFETY

Prescribed psychiatric medicines are not like other
dangerous drugs which harm the body.
Even carefully prescribed psychiatric medicines are much
too risky.
Psychiatric medicines do much more good than any minor harm
they may cause.
I believe psychiatric medicines basically poison the body.
I think psychiatric medicines usually have bad side effects.
I don't think psychiatric medicines are safe enough to be
used with human beings.
The risk of suicide is much greater than any risk in
prescribed psychiatric medications.
I would put up with some uncomfortable medication side
effects in order to get over a serious depression.
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In my opinion, any neeative side effects are minor compared
to the good psychiatric medications do.
Patients should be willing to put up with some physical
discomfort from psychiatric medicines if the medicines can
help.

I believe psychiatric medicines are too dangerous.
Even if a side effect is found in only one out of 100
patients, I still would not take psychiatric medications.
I don't care how safe a psychiatric medication is reported
to be, I still wouldn't take it.
By the time a psychiatric medication is ready to be used in
practice, it is safe.
Psychiatric medicines which are prescribed by a doctor have
been carefullly screened by scientific studies.
I can't accept the idea of ingesting chemicals, even in
small doses, into my body.

7.

INFORMATION (OBSESSIVE) VS. NAIVETE

A patient should reject psychiatric medication unless every
detail is explained carefully.
Once I had the medical facts carefully explained to me, I
would take necessary psychiatric medication.
All I need to know about psychiatric medicines is whether
the doctor thinks I should take them.
I would not take prescribed psychiatric medication even if
every detail were explained to me.
I would take psychiatric medicine prescribed for me and not
worry about scientific details.
If the doctor explains what effects the medicine might have
on me, I would take it as prescribed.
I would be hesitant to take psychiatric medication
prescribed for me without knowing all about it.
All the medical information in the world couldn't convince
me to take psychiatric medication.

Having scientific information could influence me to take
psychiatric medication prescribed for me.

8.
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TRUST VS. MISTRUST IN HELPING PROFESSIONAL

I would take psychiatric medicine if I trusted the doctor
who prescribed it.
If the doctor listened to me carefully, I would take the
psychiatric medicine he gave me.
I would follow through on taking psychiatric medicine if I
liked the way the doctor treated me.
Nothing is more important than trusting the doctor who
prescribes medicine for me.
It would be impossible for me to take psychiatric medicine
from a doctor I didn't trust.
If I did't like a doctor, I would reject medicine he wanted
me to take.
No one should take psychiatric medicine from an obnoxious
doctor.
I would take psychiatric medication I needed whether I
liked the doctor or not.
I would not take medicine from a doctor who was
disrespectful.
I believe in taking prescribed medicine even if the doctor
seems uncaring.
I'll try whatever psychiatric medicine my doctor recommends.
I have no qualms about trying psychiatric medication my
doctor recommends.
I think most people trust their doctors to know about
medications.
I would never take psychiatric medicine from a doctor I
didn't have full confidence in.
I've always felt it was important to follow doctor's orders
about medication.
If I have faith in my doctor, I always take the medication
prescribed for me.
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Having a doctor who cares is the first step toward getting
well.
I've never taken medicine out of worry about the doctor's
opinion.
I would take psychiatric medications prescribed by a

competent doctor even if he seemed uncaring.
9.

CAREFULNESS/GUILT/DUTY VS. CASUALNESS

I feel guilty when I don't take prescribed medications on
schedule.
I trust my own judgement about when to take my medication
rather than following a schedule.
I take my medicine when I feel like taking it.
I never take my medicine before I think I need it, no
matter what the written instructions are.
I get a guilty conscience if I don't follow my medication
instructions.
My conscience nags me if I don't take my prescribed
medicine.
I think it is my duty to take psychiatric medication
prescribed for me.
I would feel guilty if I didn't take psychiatric medication
prescribed for me.
Psychiatric medications should be taken if a doctor
prescribes them.
I think it would be easy for me to take prescribed
psychiatric medicine.
I certainly don't think a patient should feel guilty for
rejecting prescribed psychiatric medicine.
Whether you take prescribed psychiatric medicine exactly as
directed just isn't very important.
If psychiatric medicine were prescribed for me, I would
follow the directions carefully.
I might sample psychiatric medication prescribed for me.

I feel it would be necessary for me to comply with a
prescription for psychiatric medication.
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It is easy for me to neglect taking my medication when I
get busy.

No matter how busy I get, I always remember to take my
medication on time.
Although I have good intentions, it's hard to remember to
take my medicine regularly.
Sometimes I can forget my medication when I am too busy.
10.

COGNITIVE EFFICIENCY

Psychiatric medicine can increase a patient's ability to
think clearly about his problems.
I think prescribed psychiatric medication can help patients
concentrate better.
I believe psychiatric medication usually makes thinking
fuzzy.
Even though psychiatric medicine might help with emotions,
it usually makes it harder to think clearly.
I would not take prescribed psychiatric medicines because
they would take the edge off my thinking.
I believe prescribed psychiatric medicines usually would
make a patient's thinking clearer because of less anxiety.
Psychiatric medicine might give me the energy to think
clearly if I were depressed.
I think it's wrong to take medicine all the time because if
your thinking is dulled, you don't have a good sense of
when you're well.
11.

A)

HEALTH BELIEF MODEL DIMENSIONS (Please continue to rate
items for expression of positive, neutral, or negative
attitude toward psychiatric medicine.)
GENERAL HEALTH MOTIVATION

I am very concerned about getting sick.
The possibility of my getting sick is very low.
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I buy special foods to improve and protect my health.
I do not take vitamins regularly.
Compared to other people, I do more things to keep well.

B)

PERCEIVED SUSCEPTIBILITY/SEVERITY

I tend to be more likely than others to get sick.
In general, I am less vulnerable to illness than other
people my age.
When I do get sick, my illness tends to interfere with my
daily activities.
When I become ill, I do not tend to get severely ill.
I have had much experience with emotional illnesses.

C)

PROBABILITY THAT COMPLIANT BEHAVIOR WILL REDUCE THREAT

I believe that psychiatric medication is safe.
Most psychiatric medicine is not helpful in treating
emotional problems.
I generally have faith in doctors and medical care.
My chances for recovering from emotional illness are poor.

APPENDIX C
80-ITEM PMAS
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INFORMED CONSENT
I,

as a subject in the research project on Measuring

Att~tudes

Toward Psvchiatric

Medicine, conducted under the supervision of Vincent Glaudin, Ph.D., and
Barbara Stewart, Ph.D.
I understand that the study involves filling out a questionnaire about my
attitudes.

I understand that possible risks to me associated with this study

are losing ten minutes of class time.
It has been eXl)lained to me that the purpose of the study is to learn
about attitudes toward psychiatric medication, and about how these attitudes
might affect a person's behavior in treatment.

I may not receive any direct

benefit from participating in this study, but my participation may help to
increase knowledge which may benefit others in the future.
Kathryn Paris has offered to answer any questions I may have about the study
and what is eXl)ected of me in the study.
I understand that I am free to withdraw from participation in this study at
any time without jeopardizing either my grade in this class or my relationship
with Portland State University.
I have read and understand the foregoing information.

If you experience problems that are the result of your participation in this
study, please contact Richard Streeter, Office of Graduate Studies and Research.
105 Neuberger Hall, Portland State University, 229-3423.
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PSYCHIATRIC

I.

MEDICI~E

ATTITUDE SCALE

Demographics
Please fill in or check the appropriate response:
Age in years - - - - -

Sex:

Male_ __
Female_ _

Check the statement that applies to you:
I have taken prescribed psychiatric medicine in the past but am not
currently taking it.
I am currently taking prescribed psychiatric medicine.
I have never taken prescribed psychiatric medicine.
II.

Instructions
Circle the letter which best corresponds to the way you feel about each statement.
Example
The PSU library needs to be open more hours.

Strongly
Agree
b

c

d

Strongly
Disagree
f
e

b

c

d

e

©
a

I think that public college tuition should be raised.
III.

Questionnaire

©

Strongly
Agree
b
1. a

c

d

Strongly
Disagree
f
e

2.

a

b

c

d

e

f

l.

In my opinion, any negative side effects are minor
compared to the good psychiatric medications do.

2.

The best thing about
they work.

3.

I'm convinced that it isn't natural to reduce
emotional suffering by using psychiatric
medication.

3.

a

b

c

d

e

f

4.

I never take my medicine before I think I need it,
no matter what the written instructions are.

4.

a

b

c

d

e

f

s.

Psychiatric medicines usually cover up problems
that should be faced.

s.

a

b

c

d

e

f

6.

If I didn't like a doctor, I would reject medicine
he wanted me to take.

6.

a

b

c

d

e

f

7.

I would take prescribed psychiatric medication for
the sake of my loved ones.

7.

a

b

c

d

e

f

8.

If psychiatric medicine were prescribed for me, 1
would follow the directions carefully.

8.

a

b

c

d

e

f

psyc~iatric

medicines is that
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Strongly

Strongly
a

h

I feel it would be necessary for me to comply
with a prescription for psychiatric medication.

10. a

b

c

d

I would take psychiatric medications prescribed

l l. a

b

c

d

e

9.

Sven caretully ?rescribed psychiatric medicines
~re much too risky.

10.
11.

~ Dit11.:.r~t!

q.

by a competent doctor even if he seemed uncaring.

12.

I don't believe in psychiatric medicines.

12. a

b

c

d

e

13.

Psychiatric medications are habit-forming.

13. a

b

c

d

e

f

14.

I would put up with some uncomfortable medication
side effects in order to get over a serious
depression.

14. a

b

c

d

e

f

15.

I would be relieved to find out that a close
friend was taking medication for depression.

15.

a

c

b

f

e

d

16.

I believe all psychiatric medicines present a very
real danger of addiction.

16. a

b

c

d

e

f

17.

Whether you take prescribed psychiatric medicine
exactly as directed just isn't very important.

17. a

b

c

d

e

f

18.

Psychiatric medicine might give me the energy to
think clearly if I were depressed.

18. a

b

c

d

e

f

19.

I believe people should face their problems without 19. a
psychiatric medicine.

b

c

d

e

f

20.

I think taking psychiatric medicine is a realistic
method to lessen discomfort.

20. a

b

c

d

e

f

41.

une of the best things about most psychiatric
medications is that there is no risk of addiction.

21. a

b

c

d

e

f

22.

Unless friends kept encouraging me to take prescribed psychiatric medicine, I would stop.

22. a

b

c

d

e

f

23.

I would rather have psychological counseling
forever than take psychiatric medicines.

23. a

b

c

d

e

f

24.

I would not take prescribed psychiatric medicines
because they take the edge off my thinking.

24. a

b

c

d

e

f

25.

Psychiatric medicine can increase a patient's
ability to think clearly about his problems.

25. a

b

c

d

e

f

26.

The only value psychiatric medicine has comes from
the power of suggestion.

26. a

b

c

d

e

f

27.

I would never take psychiatric medicine from a
doctor I didn't have full confidence in.

27. a

b

c

d

e

f

77

Strong l ~;

Strongly

Di~agre~

..\~ree

28.

I'm afraid that if l took a prescribed psychiatric medicine, I would become dependent on it.

:!8.

a

b

c

d

29.

Psychiatric medication can help with all kinds
of problems.

29.

a

b

c

d

30.

A patient should reject psychiatric medication
unless every detail is explained carefully.

30.

a

b

c

d

31.

I think it's wrong to take medicine all the time
31.
because if your thinking is dulled, you don't have
a good sense of when you're well.

a

b

c

d

e

32.

I could take prescribed psychiatric medicines
without becoming dependent on them.

32.

a

b

c

d

e

f

33.

Having to take psychiatric medicines is no way
to live.

33.

a

b

c

d

e

f

34.

I think psychiatric medicines usually have bad
side effects.

34.

a

b

c

d

e

f

35.

Once I had the medical facts carefully explained
to me, I would take necessary psychiatric medication.

35.

a

b

c

d

e

f

36.

I think some problems can be faced up to better
with the support of psychiatric medications.

36.

a

b

c

d

e

f

37.

I would not take prescribed psychiatric medication even if every detail were explained to me.

37.

a

b

c

d

e

f

38.

The trouble with psychiatric medicines is that
they just don't work.

38.

a

b

c

d

e

f

39.

Having the scientific information would influence me to take psychiatric medication
prescribed for me.

39.

a

b

c

d

e

f

40.

I would take psychiatric medication prescribed
for me because I believe it is pretty effective.

40.

a

b

c

d

e

f

41.

Carefully prescribed psychiatric medicines have
no danger of addiction.

41.

a

b

c

d

e

f

42.

If my family seemed uninterested in my treatment, 42.
I would throw prescribed psychiatric medicine down
the sink.

a

b

c

d

e

f

43.

No matter how busy t get, I always remember to
take my medication on.time.

43.

a

b

c

d

e

f

44.

I would not take psychiatric medication prescribed
to me if my family and friends seemed very
interested.

44.

a

b

c

d

e

f

45.

I believe psychiatric medication usually makes
thinking fuzzy.

45.

a

b

c

d

e

f

e

f

f
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Str:)n.~i:·

Strongly
Agree

Ll is.::i~r1.~-=

46.

Psychiatric medication can help provioe the
energy to face overwhelming problems.

46.

·'3.

b

c

d

47.

I would be hesitant to take psychiatric medication prescribed for me without knowing all
about it.

47.

a

b

c

d

48.

When I have emotional problems, I want psychiatric medicine prescribed for me.

48.

a.

b

c

d

e

f

49.

Host prescribed psychiatric medicines are safe
to take over a period of months.

49.

a

b

c

d

e

f

50.

I don't care how safe a psychiatric medication
is reported to be, I still wouldn't take it.

50.

a

b

c

d

e

f

51.

I would not take medicine from a doctor who was
disrespectful.

51.

a

b

c

d

e

f

32.

I think prescribed psychiatric medication can
help patients concentrate better.

52.

a

b

c

d

e

f

53.

I take my medication regularly regardless of
what my family thinks of it.

53.

a

b

c

d

e

f

54.

I believe psychiatric medicines basically poison
the body.

54.

a

b

c

d

e

f

SS.

It is easy for me to neglect taking my medication
when I get busy.

SS.

a

b

c

d

e

f

56.

I would take psychiatric medicine prescribed for
me and not worry about scientific details.

56.

a

b

c

d

e

f

57.

Psychiatric medicine is only an emotional crutch.

57.

a

b

c

d

e

f

58.

Psychiatric medicines are too weak to help treat
big problems.

58.

a

b

c

d

e

f

59.

If the doctor explains what effects the medicine
might have on me, I would take it as prescribed.

59.

a

b

c

d

e

f

60.

I would take psychiatric medication I needed
whether I liked the doctor or not.

60.

a

b

c

d

e

f

61.

I think it's always best to seek medical help for
severe depression.

61.

a

b

c

d

e

f

62.

It would be impossible for me to take psychiatric
medicine from a doctor I didn't trust.

62.

a

b

c

d

e

f

63.

I see psychiatric medicine as a last resort to
coping with emotional problems.

63.

a

b

c

d

e

f

64.

You can't expect a patient to take psychiatric
medication if no one cares.

64.

a

b

c

d

e

g

e
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Strongly
Disagree

Strongly
Agree
65.

Psvchiatric medicines which are prescribed by
a doctor have been carefully screened by
scientific studies.

65.

a

b

c

d

e

f

66.

Frequently, patients can learn new ways of coping
because psychiatric medicines break up old anxiety
patterns.

66.

a

b

c

d

e

f

67.

Even though psychiatric medicine might help with
emotions, it usually makes it harder to think
clearly.

67.

a

b

c

d

e

68.

I have no qualms about trying psychiatric medication my doctor recommends.

68.

a

b

c

d

e

f

69.

I think a patient should take prescribed psychiatric medicine even if family and friends don't
understand.

69.

a

b

c

d

e

f

70.

I think psychiatric medications almost always
block you from having feelings you should
experience.

70.

a

b

c

d

e

f

71.

I think it is my duty to take psychiatric medication prescribed for me.

71.

a

b

c

d

e

f

72.

I'll try whatever psychiatric medicine my doctor
recommends.

72.

a

b

c

d

e

f

73.

Once you begin taking psychiatric medicine, it is
hard to give it up.

73.

a

b

c

d

e

f

74.

I believe prescribed psychiatric medicines usually
would make a patient's thinking clearer because
of less anxiety.

74.

a

b

c

d

e

f

75.

All the medical informa~ion in the world couldn't
convince me to take psychiatric medication.

75.

a

b

c

d

e

f

76.

It would be easy for me to forget to take my
medication.

76.

a

b

c

d

e

f

77.

I believe psychiatric medications can make it
possible to learn new behavior in frightening
situations.

77.

a

b

c

d

e

f

78.

The risk of suicide is much greater than any
risk in prescribed psychiatric medications.

78.

a

b

c

d

e

f

79.

Being more relaxed is something you can count on
from taking psychiatric medicines.

79.

a

b

c

d

e

f

80.

Other people's opinions would never stop me from
taking the medication ! need.

80.

a

b

c

d

e

f

APPENDIX D
PSYCHIATRIC MEDICINE ATTITUDE SCALE

81

PSYCHIATRIC MEDICINE ATTITUDE SCALE A
NAME._____________________________________________DATE__________________
Age_ _ Sex_ Years of education completed_ _ _Oc:c:upation_ _ _ _ _ _ _ _ _ _ _ _ _ __
Check al I the statements that apply to you:
I have never taken prescribed psychiatric medicine.
I have taken prescribed psychiatric: medicine in the past.
I am currently taking prescribed psychiatric medici~e.
I am considering starting to take psychiatric medicine.
A person I know well (relative, friend) is currently taking or
has taken prescribed psychiatric medicine.
INSTRUCTIONS

.9!s!!. the

letter which best corresponds to the way you feel about each statement.

EXAMPLE

1•

The streets where I live are adequately paved.

Strongly
~
Agree
b
1. a

2.

My neighbors are friendly.

2.

a

@

c:

d

e

(!)

c:

d

•

f
Sh'ongly

Strof9y
~

QUESTIONNAIRE
1.

Strongly
Oi10gree

~

Psychiatric !MdlciM can help prowide the ......,, to face ov.rwheimi"9 prabl.,..

01..-

•
•
•

1.

0

b

c:

d

2.

0

b

c:

d

3.

0

b

c:

d

"'·

0

b

c:

d

e

5.

Q

b

c

d

6. The trouble with peyc:hiotric mediciMI i1 thot they just don't woril.

6.

Q

b

c

d

•
•

7.

I would take pa)IChiotric: medicine preKribed for me and nat worry about scientific details.

7.

Q

b

c

d

•

8.

Even carefully preteribed pa~hlatric medici,.. ore much toa risky.

8.

Q

b

c

d

9. Once I head the mediccd factl cCll'ltfully ..Pained to me, I would lake nee......, peyc:hiatric medication. 9.

Q

b

c

d

•
•

10. I doti't believe in pl)IChiotPic medlcinea.

0

b

c

d

•

11.

Q

b

c

d

•

effects in Ofder to ;et ovw o aerioul . . . . .ion. 12.

a

b

c

d

e

13.

Q

b

c

d

e

1-4. I thi'* a patient ..,Id take ...-:ribed peychiotPlc medlci . . even if family and frl..- doti't undentand. 1-4.

Q

b

c

d

e

•
•
•

2. I think pl)IChiotrlc !lllldlcU.._ uually have -.. 1ide effects.
3.

...

I would talut fl'YChlalric !lllldlcation

..-a.. far , . ~ I believe it ia pretty effective.

It is easy for me to neelec:t taking my !lllldication wMrl I 99f buay.

5. I be4ieve pl)IChiotPic medicatione con molce it po11ible to 1.-n new behavior in ffight9nift9 situotionl.

10.

11. I believe pretCribed paychlatric medlclMS uudly would make a potl•t 1 thinking cl..., becou•
of • - anxiety.
1

12. I would put up with IOll'le '-riCCIAfoituble medication
13. Even

11•

thou9h pi11Chiotric Ndlcine might help with efll0tion1,

it U1UC1lly rnalcel It harder to think c:l... ly.

15. Once you betin laking paychicnric medJciM, it ii t.d to give It up.

15.

a

b

c

d

16. I have no ~"" about trying paychiotPlc Ndlcotlon my cb:tor recoi1-.lda.

16.

a

b

c

d

17.

Q

b

c

d

18. I would not take sw-cribed Pl)'Chiotric: Ndlc:atlon even If every detail wwe exploined to me.

18.

Q

b

c:

d

19. Whe~ you take pNICribed paychiotrlc medicine uoctly as directed juat i1n't very importQnt.

19.

a

b

20. I would take prescribed pt)IChiatric medication for the taile of my loved onea.

20.

Q

b

17. I would be retl.ved to find a..t that o c:I01e friend W9

"*lft9 lhlldlcotlon for .,_.ion.

c

•

d

•

d

•
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PSYCHIATRIC MEDICINE ATTITUDE SCALE 8
NAME

DATE:.--------:----------------------------------------Age_ Sex_ _ Yean of education completed_ _ _Occupation._ _ _ _ _ _ _ _ _ _ _ _ _ __
Check all the statements that apply to you:
I have never tak.n presc:ribed psychiatric medicine.
I have taken prescribed psychiatric medicirte in the past.
I om currently taking prescribed psychiatric medicine.
I am considering starting to take psychiatric medicine.
A person I know wel I (relative, friend) is currently taking or
has taken prescribed psychiatric medicine.
INSTRUCTIONS
~

the letter which best corresponds to the way you feel about eoch statement.

1.

The streets where I live are adequately paved.

Strongjy
~
Agree
b
1. a

2.

My neighbors are friendly.

2.

EXAMPLE

a

~

@

Strongly
Disagree

c

d

• (!)

c

d

e

f

Slrongfy

QUESTIONNAIRE

S"°""y
DilG9""

A.I.

0

b

c

d

•

2.

a

b

c

d

3. Hcwi"I the tcientlflc il1ionnotlon wouAd influence nie to hike paychlotrlc medication pNeCribecUar me ..

3.

0

b

c

d

•
•

••

Psychiatric medici,... 111uaUy cover up pnibl... that should be faced.

••

0

b

c

d

s.

I 'II try wtlatw¥er Pl)'Chlotric medicine my doctor l'9COlllnl9ndl.

5.

0

b

c

d

6. I don't care how IOfe a p1ychiatric medication i1 r.,orted to be, I still wouldn't take it.

6.

Q

b

c

d

7. One of the belt things about moat p1ychiotric mec:lication i1 that there i1 no ritk of addiction.

7.

Q

b

c

d

8. All the medical information in the world coul•'t convince me to take paychiotrlc medication.

8.

Q

b

c

d

9. If the doctor explolN what eH.ctl the medicine might hcwe on me, I would take it 01 preecribed.

9.

Q

b

c

d

10. I thi .. paychlatrlc mecllcatlona ollllOlt alwaya black you ffOlft hcwi"I f•lift91 you anauld experience.

10.

0

b

c

d

11. I tolce my medication regulariy regard&- of what my family thl• of It.

11.

Q

b

c

d

•

12. I wauld rather hcwe Pl)'ChoAQ9icai cou...tl"I ro.-. ttw. take fllYChiotrlc medlci,..

12.

Q

b

c

d

13. 1'm afraid that if I toaA& a pr..:rlbed ~hlatric medicine, I would becanw .,.,...,. on it.

13.

0

b

c

d

•
•

14. Psychiatric medicine ntitht gi.,. me the ..... to think clearfy if l were .,._...

14.

a

b

c

d

e

15. Psychiatric medlcottor. ore habit-fanning.

15.

0

b

c

d

16.

0

b

c

d

17. I thl,. .,... proDI... can be faced up to better with the IUflPO"' of plydtlatrlc medlcatlona.

17.

a

b

c

d

•
•
•

18. F,..,.mty, potientl con learn new waya of copt"I-... fllYChiatrlc medlclnea bNak

18.

0

b

c

d

•

'9.1 would be helin.tt to tab p1ychiotrlc medication pr..:ribed for me without kr»Wlnt oll about it.

19.

Q

b

c

d

•

20. I think pr..:ribed paychiatric medication can hefp patientl concetttroN better.

20.

Q

b

c

d

•

l ~ I thi,. hlki"I p1ychiotric medicine la a realistic method to 1-.n dllCCllllfort.
2. I beileve

~hiotric

medication UIUGlly ...... thinkl"I fuzzy.

16. I would ~ p1ychlotric: medication l needed

wmttw l Ilked tt. cmctar or not.

up old anxiety pottwna.

•
•
•
•
•
•
•

f

